OpenURL Connection Search

Select item for more details and to access through your institution.

Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in...
Published in:
JNCI: Journal of the National Cancer Institute, 1995, v. 87, n. 18, p. 1394, doi. 10.1093/jnci/87.18.1394
By:
- Schwartz, Gary K.;
- Hamitovitz-Friedman, Adriana
Publication type:
Article
Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.
Published in:
1993
By:
- Schwartz, Gary. K.;
- Jiang, Jack;
- Kelsen, David;
- Albino, Anthony P.;
- Schwartz, G K;
- Jiang, J;
- Kelsen, D;
- Albino, A P
Publication type:
journal article
Inhibition of Invasion of Invasive Human Bladder Carcinoma Cells by Protein Kinase C Inhibitor Staurosporine.
Published in:
JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 22, p. 1753
By:
- Schwartz, Gary K.;
- Redwood, S. Mark;
- Ohnuma, Takao;
- Holland, James F.;
- Droller, Michael J.;
- Liu, Brian C.–S.
Publication type:
Article
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01865-2
By:
- Wu, Xun;
- Cheng, Yi-Shing Lisa;
- Matthen, Mathew;
- Yoon, Angela;
- Schwartz, Gary K.;
- Bala, Shashi;
- Taylor, Alison M.;
- Momen-Heravi, Fatemeh
Publication type:
Article
Community education to enhance the more equitable use of precision medicine in Northern Manhattan.
Published in:
Journal of Genetic Counseling, 2020, v. 29, n. 2, p. 247, doi. 10.1002/jgc4.1244
By:
- Hillyer, Grace C.;
- Schmitt, Karen M.;
- Reyes, Andria;
- Cruz, Alejandro;
- Lizardo, Maria;
- Schwartz, Gary K.;
- Terry, Mary Beth
Publication type:
Article
PMA-induced reduction in invasiveness is associated with hyperphosphorylation of MARCKS and talin in invasive bladder cancer cells.
Published in:
International Journal of Cancer, 1998, v. 75, n. 5, p. 774, doi. 10.1002/(SICI)1097-0215(19980302)75:5<774::AID-IJC18>3.0.CO;2-6
By:
- Yokoyama, Yasuhiro;
- Ito, Tetsushi;
- Hanson, Veneta;
- Schwartz, Gary K.;
- Aderem, Alan A.;
- Holland, James F.;
- Tamaya, Teruhiko;
- Ohnuma, Takao
Publication type:
Article
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.
Published in:
International Journal of Cancer, 1995, v. 64, n. 1, p. 37, doi. 10.1002/ijc.2910640109
By:
- Nabeya, Yoshihiro;
- Loganzo, Frank;
- Maslak, Peter;
- Lai, Lawrence;
- De Oliveira, Alice R.;
- Schwartz, Gary K.;
- Blundell, Maude L.;
- Altorki, Nasser K.;
- Kelsen, David P.;
- Albino, Anthony P.
Publication type:
Article
IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting.
Published in:
Journal of Pathology, 2010, v. 221, n. 3, p. 300, doi. 10.1002/path.2715
By:
- Hajdu, Mihai;
- Singer, Samuel;
- Maki, Robert G;
- Schwartz, Gary K;
- Keohan, Mary Lou;
- Antonescu, Cristina R
Publication type:
Article
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
Published in:
Investigational New Drugs, 2024, v. 42, n. 1, p. 127, doi. 10.1007/s10637-024-01420-8
By:
- Emiloju, Oluwadunni E.;
- Yin, Jun;
- Koubek, Emily;
- Reid, Joel M.;
- Borad, Mitesh J.;
- Lou, Yanyan;
- Seetharam, Mahesh;
- Edelman, Martin J.;
- Sausville, Edward A.;
- Jiang, Yixing;
- Kaseb, Ahmed O.;
- Posey, James A.;
- Davis, Sarah L.;
- Gores, Gregory J.;
- Roberts, Lewis R.;
- Takebe, Naoko;
- Schwartz, Gary K.;
- Hendrickson, Andrea E. Wahner;
- Kaufmann, Scott H.;
- Adjei, Alex A.
Publication type:
Article
Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype.
Published in:
PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040439
By:
- Ho, Alan L.;
- Musi, Elgilda;
- Ambrosini, Grazia;
- Nair, Jayasree S.;
- Vasudeva, Shyamprasad Deraje;
- de Stanchina, Elisa;
- Schwartz, Gary K.
Publication type:
Article
Preclinical study of treatment response in HCT-116 cells and xenografts with <sup>1</sup>H-decoupled <sup>31</sup>P MRS.
Published in:
NMR in Biomedicine, 2011, v. 24, n. 9, p. 1159, doi. 10.1002/nbm.1674
By:
- Darpolor, Moses M.;
- Kennealey, Peter T.;
- Le, H. Carl;
- Zakian, Kristen L.;
- Ackerstaff, Ellen;
- Rizwan, Asif;
- Chen, Jin-Hong;
- Sambol, Elliot B.;
- Schwartz, Gary K.;
- Singer, Samuel;
- Koutcher, Jason A.
Publication type:
Article
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.
Published in:
Cancers, 2022, v. 14, n. 17, p. 4334, doi. 10.3390/cancers14174334
By:
- Wagner, Michael J.;
- Hennessy, Cassandra;
- Beeghly, Alicia;
- French, Benjamin;
- Shah, Dimpy P.;
- Croessmann, Sarah;
- Vilar-Compte, Diana;
- Ruiz-Garcia, Erika;
- Ingham, Matthew;
- Schwartz, Gary K.;
- Painter, Corrie A.;
- Chugh, Rashmi;
- Fecher, Leslie;
- Park, Cathleen;
- Zamulko, Olga;
- Trent, Jonathan C.;
- Subbiah, Vivek;
- Khaki, Ali Raza;
- Tachiki, Lisa;
- Nakasone, Elizabeth S.
Publication type:
Article
A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma.
Published in:
Cancers, 2021, v. 13, n. 21, p. 5504, doi. 10.3390/cancers13215504
By:
- Shoushtari, Alexander N.;
- Khan, Shaheer;
- Komatsubara, Kimberly;
- Feun, Lynn;
- Acquavella, Nicolas;
- Singh-Kandah, Shahnaz;
- Negri, Tiffany;
- Nesson, Alexandra;
- Abbate, Kelly;
- Cremers, Serge;
- Musi, Elgilda;
- Ambrosini, Grazia;
- Lee, Shing;
- Schwartz, Gary K.;
- Carvajal, Richard D.
Publication type:
Article
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers.
Published in:
Cancers, 2020, v. 12, n. 7, p. 1768, doi. 10.3390/cancers12071768
By:
- Amin, Hesham M.;
- Morani, Ajaykumar C.;
- Daw, Najat C.;
- Lamhamedi-Cherradi, Salah-Eddine;
- Subbiah, Vivek;
- Menegaz, Brian A.;
- Vishwamitra, Deeksha;
- Eskandari, Ghazaleh;
- George, Bhawana;
- Benjamin, Robert S.;
- Patel, Shreyaskumar;
- Song, Juhee;
- Lazar, Alexander J.;
- Wang, Wei-Lien;
- Kurzrock, Razelle;
- Pappo, Alberto;
- Anderson, Peter M.;
- Schwartz, Gary K.;
- Araujo, Dejka;
- Cuglievan, Branko
Publication type:
Article
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma.
Published in:
Sarcoma, 2015, v. 2015, p. 1, doi. 10.1155/2015/532478
By:
- Dickson, Mark A.;
- D’Adamo, David R.;
- Keohan, Mary L.;
- D’Angelo, Sandra P.;
- Carvajal, Richard D.;
- Gounder, Mrinal M.;
- Maki, Robert G.;
- Qin, Li-Xuan;
- Lefkowitz, Robert A.;
- McKennon, Olivia R.;
- Hirst, Catherine M.;
- Schwartz, Gary K.;
- Tap, William D.
Publication type:
Article
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.
Published in:
2013
By:
- Maki, Robert G.;
- Jungbluth, Achim A.;
- Gnjatic, Sacha;
- Schwartz, Gary K.;
- D'Adamo, David R.;
- Keohan, Mary Louise;
- Wagner, Michael J.;
- Scheu, Kelly;
- Chiu, Rita;
- Ritter, Erika;
- Kachel, Jennifer;
- Lowy, Israel;
- Old, Lloyd J.;
- Ritter, Gerd
Publication type:
Journal Article
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.
Published in:
Sarcoma, 2013, p. 1, doi. 10.1155/2013/168145
By:
- Maki, Robert G.;
- Jungbluth, Achim A.;
- Gnjatic, Sacha;
- Schwartz, Gary K.;
- D'Adamo, David R.;
- Keohan, Mary Louise;
- Wagner, Michael J.;
- Scheu, Kelly;
- Chiu, Rita;
- Ritter, Erika;
- Kachel, Jennifer;
- Lowy, Israel;
- Old, Lloyd J.;
- Ritter, Gerd
Publication type:
Article
Ifosfamide May Be Safely Used in Patients with End Stage Renal Disease on Hemodialysis.
Published in:
2009
By:
- Latcha, Sheron;
- Maki, Robert G.;
- Schwartz, Gary K.;
- Flombaum, Carlos D.
Publication type:
Case Study
A phase I trial of a modified, dose intensive FAMTX regimen (High dose 5-fluorouracil + doxorubicin + high dose methotrexate + leucovorin) with oral uridine rescue.
Published in:
Cancer (0008543X), 1996, v. 78, n. 9, p. 1988, doi. 10.1002/(SICI)1097-0142(19961101)78:9<1988::AID-CNCR21>3.0.CO;2-T
By:
- Schwartz, Gary K.;
- Christman, Kathy;
- Saltz, Leonard;
- Casper, Ephraim;
- Quan, Valerie;
- Bertino, Joseph;
- Martin, Daniel S.;
- Colofiore, Joseph;
- Kelsen, David
Publication type:
Article
Defining the invasive phenotype of proximal gastric cancer cells.
Published in:
1994
By:
- Schwartz, Gary K.;
- Wang, Henry;
- Lampen, Nina;
- Altorki, Nasser;
- Kelsen, David;
- Albino, Anthony P.;
- Schwartz, G K;
- Wang, H;
- Lampen, N;
- Altorki, N;
- Kelsen, D;
- Albino, A P
Publication type:
journal article
Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.
Published in:
1993
By:
- Casper, Ephraim S.;
- Christman, Kathy L.;
- Schwartz, Gary K.;
- Johnson, Bruce;
- Brennan, Murray F.;
- Bertino, Joseph R.;
- Casper, E S;
- Christman, K L;
- Schwartz, G K;
- Johnson, B;
- Brennan, M F;
- Bertino, J R
Publication type:
journal article
Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.
Published in:
1993
By:
- Altorki, Nasser;
- Schwartz, Gary K.;
- Blundell, Maude;
- Davis, Brigid M.;
- Kelsen, David P.;
- Albino, Anthony P.;
- Altorki, N;
- Schwartz, G K;
- Blundell, M;
- Davis, B M;
- Kelsen, D P;
- Albino, A P
Publication type:
journal article
High frequency of simultaneous loss of p16 and p16β gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.
Published in:
Oncogene, 1997, v. 15, n. 12, p. 1481, doi. 10.1038/sj.onc.1201295
By:
- Hayashi, Kazuhiko;
- Metzger, Ralf;
- Salonga, Dennis;
- Danenberg, Kathleen;
- Leichman, Lawrence P;
- Fink, Ulrich;
- Sendler, Andreas;
- Kelsen, David;
- Schwartz, Gary K;
- Groshen, Susan;
- Lenz, Heinz-Josef;
- Danenberg, Peter V
Publication type:
Article
A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomasPresented, in part, at the 39th Annual Meeting of the American Society of Clinical Oncology, Chicago, Illinois, May 31June 3, 2003 (abstract 3291).
Published in:
Cancer (0008543X), 2005, v. 103, n. 7, p. 1431
By:
- Robert G. Maki;
- Andrew S. Kraft;
- Kelly Scheu;
- Jennifer Yamada;
- Scott Wadler;
- Cristina R. Antonescu;
- John J. Wright;
- Gary K. Schwartz
Publication type:
Article
A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.
Published in:
2001
By:
- O'Reilly, Eileen M.;
- Stuart, Keith E.;
- Sanz-Altamira, Pedro M.;
- Schwartz, Gary K.;
- Steger, Carolyn M.;
- Raeburn, Lynn;
- Kemeny, Nancy E.;
- Kelsen, David P.;
- Saltz, Leonard B.;
- O'Reilly, E M;
- Stuart, K E;
- Sanz-Altamira, P M;
- Schwartz, G K;
- Steger, C M;
- Raeburn, L;
- Kemeny, N E;
- Kelsen, D P;
- Saltz, L B
Publication type:
journal article
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
Published in:
Cancer (0008543X), 1999, v. 86, n. 10, p. 2034, doi. 10.1002/(SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.0.CO;2-P
By:
- Fata, Farid;
- O'Reilly, Eileen;
- Ilson, David;
- Pfister, David;
- Leffel, David;
- Kelsen, David P.;
- Schwartz, Gary K.;
- Casper, Ephraim S.
Publication type:
Article
TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma.
Published in:
Nature Communications, 2016, v. 7, n. 8, p. 12609, doi. 10.1038/ncomms12609
By:
- Jung, Joonil;
- Lee, Joon Sang;
- Dickson, Mark A.;
- Schwartz, Gary K.;
- Le Cesne, Axel;
- Varga, Andrea;
- Bahleda, Rastilav;
- Wagner, Andrew J.;
- Choy, Edwin;
- de Jonge, Maja J.;
- Light, Madelyn;
- Rowley, Steve;
- Macé, Sandrine;
- Watters, James
Publication type:
Article
Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials.
Published in:
2018
By:
- Yokota, Tomoya;
- Bendell, Johanna;
- LoRusso, Patricia;
- Tsushima, Takahiro;
- Desai, Ved;
- Kenmotsu, Hirotsugu;
- Watanabe, Junichiro;
- Ono, Akira;
- Murugesan, Bhavani;
- Silva, Joseph;
- Naito, Tateaki;
- Greenberg, Jonathan;
- Kumar, Prasanna;
- Wang, Yibin;
- Jikoh, Takahiro;
- Shiga, Ryota;
- Hyman, David M.;
- Ho, Alan Loh;
- Spriggs, David R.;
- Schwartz, Gary K.
Publication type:
journal article
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol.
Published in:
Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1113, doi. 10.1007/s00280-010-1269-1
By:
- Dickson, Mark A.;
- Shah, Manish A.;
- Rathkopf, Dana;
- Tse, Archie;
- Carvajal, Richard D.;
- Nian Wu;
- Lefkowitz, Robert A.;
- Gonen, Mithat;
- Cane, Lauren M.;
- Dials, Heather J.;
- Schwartz, Gary K.
Publication type:
Article
Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents.
Published in:
Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 245, doi. 10.1007/s00280-009-1153-z
By:
- Goteti, Kosalaram;
- Garner, C. Edwin;
- Utley, Lucas;
- Jing Dai;
- Ashwell, Susan;
- Moustakas, Demetri T.;
- Gönen, Mithat;
- Schwartz, Gary K.;
- Kern, Steven E.;
- Zabludoff, Sonya;
- Brassil, Patrick J.
Publication type:
Article
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.
Published in:
2008
By:
- Ku GY;
- Ilson DH;
- Schwartz LH;
- Capanu M;
- O'Reilly E;
- Shah MA;
- Kelsen DP;
- Schwartz GK;
- Ku, Geoffrey Y;
- Ilson, David H;
- Schwartz, Lawrence H;
- Capanu, Marinela;
- O'Reilly, Eileen;
- Shah, Manish A;
- Kelsen, David P;
- Schwartz, Gary K
Publication type:
journal article
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 875, doi. 10.1007/s00280-008-0677-y
By:
- Ku, Geoffrey Y.;
- Ilson, David H.;
- Schwartz, Lawrence H.;
- Capanu, Marinela;
- O'Reilly, Eileen;
- Shah, Manish A.;
- Kelsen, David P.;
- Schwartz, Gary K.
Publication type:
Article
Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis.
Published in:
Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 5, p. 389, doi. 10.1007/s002800051007
By:
- Hsueh, Chung-Tsen;
- Chiu, Chang-Fang;
- Kelsen, David P.;
- Schwartz, Gary K.
Publication type:
Article
Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: Clinical and molecular correlates.
Published in:
International Journal of Cancer, 2013, v. 132, n. 7, p. 1711, doi. 10.1002/ijc.27800
By:
- Dickson, Mark A.;
- Schwartz, Gary K.;
- Antonescu, Cristina R.;
- Kwiatkowski, David J.;
- Malinowska, Izabela A.
Publication type:
Article
Early treatment-related neutropenia predicts response to palbociclib.
Published in:
2020
By:
- McAndrew, Nicholas P.;
- Dickson, Mark A.;
- Clark, Amy S.;
- Troxel, Andrea B.;
- O'Hara, Mark H.;
- Colameco, Christopher;
- Gallager, Maryann;
- Gramlich, Kristi;
- Zafman, Kelly;
- Vaughn, David;
- Schwartz, Gary K.;
- O'Dwyer, Peter J.;
- DeMichele, Angela
Publication type:
journal article
E-cigarette Use Among Young Adult Patients: The Opportunity to Intervene on Risky Lifestyle Behaviors to Reduce Cancer Risk.
Published in:
Journal of Community Health, 2022, v. 47, n. 1, p. 94, doi. 10.1007/s10900-021-01027-7
By:
- Hillyer, Grace C.;
- Nazareth, Meaghan;
- Lima, Sarah;
- Schmitt, Karen M.;
- Reyes, Andria;
- Fleck, Elaine;
- Schwartz, Gary K.;
- Terry, Mary Beth
Publication type:
Article
Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach.
Published in:
Journal of Clinical Pharmacology, 2017, v. 57, n. 9, p. 1159, doi. 10.1002/jcph.902
By:
- Sun, Wan;
- O'Dwyer, Peter J.;
- Finn, Richard S.;
- Ruiz‐Garcia, Ana;
- Shapiro, Geoffrey I.;
- Schwartz, Gary K.;
- DeMichele, Angela;
- Wang, Diane
Publication type:
Article
Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma.
Published in:
CTS: Clinical & Translational Science, 2024, v. 17, n. 2, p. 1, doi. 10.1111/cts.13709
By:
- Gao, Lan;
- Kaushik, Diksha;
- Van Tine, Brian A.;
- Ingham, Matthew A.;
- Attia, Steven;
- Meyer, Christian F.;
- Schwartz, Gary K.;
- Maliakal, Pius;
- Baird, John D.;
- Ma, Jiyuan;
- Barrett, Rosemary;
- D'Silva, Dhiren;
- O'Keefe, Kylie;
- Kong, Ronald
Publication type:
Article
Clinical trial enrollment of adolescents and young adults with sarcoma.
Published in:
Cancer (0008543X), 2017, v. 123, n. 18, p. 3434, doi. 10.1002/cncr.30757
By:
- Davis, Lara E.;
- Janeway, Katherine A.;
- Weiss, Aaron R.;
- Chen, Yen-Lin E.;
- Scharschmidt, Thomas J.;
- Krailo, Mark;
- Glade Bender, Julia L.;
- Kopp, Lisa M.;
- Patel, Shreyaskumar R.;
- Schwartz, Gary K.;
- Horvath, L. Elise;
- Hawkins, Douglas S.;
- Chuk, Meredith K.;
- Reinke, Denise K.;
- Gorlick, Richard G.;
- Randall, R. Lor
Publication type:
Article
Patient-derived xenografts for individualized care in advanced sarcoma.
Published in:
Cancer (0008543X), 2014, v. 120, n. 13, p. 2006, doi. 10.1002/cncr.28696
By:
- Stebbing, Justin;
- Paz, Keren;
- Schwartz, Gary K.;
- Wexler, Leonard H.;
- Maki, Robert;
- Pollock, Raphael E.;
- Morris, Ronnie;
- Cohen, Richard;
- Shankar, Arjun;
- Blackman, Glen;
- Harding, Victoria;
- Vasquez, David;
- Krell, Jonathan;
- Ciznadija, Daniel;
- Katz, Amanda;
- Sidransky, David
Publication type:
Article
Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.
Published in:
2013
By:
- Luke, Jason J;
- Callahan, Margaret K;
- Postow, Michael A;
- Romano, Emanuela;
- Ramaiya, Nikhil;
- Bluth, Mark;
- Giobbie-Hurder, Anita;
- Lawrence, Donald P;
- Ibrahim, Nageatte;
- Ott, Patrick A;
- Flaherty, Keith T;
- Sullivan, Ryan J;
- Harding, James J;
- D'Angelo, Sandra;
- Dickson, Mark;
- Schwartz, Gary K;
- Chapman, Paul B;
- Wolchok, Jedd D;
- Hodi, F Stephen;
- Carvajal, Richard D
Publication type:
journal article
Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma.
Published in:
Cancer (0008543X), 2013, v. 119, n. 20, p. 3687, doi. 10.1002/cncr.28282
By:
- Luke, Jason J.;
- Callahan, Margaret K.;
- Postow, Michael A.;
- Romano, Emanuela;
- Ramaiya, Nikhil;
- Bluth, Mark;
- Giobbie‐Hurder, Anita;
- Lawrence, Donald P.;
- Ibrahim, Nageatte;
- Ott, Patrick A.;
- Flaherty, Keith T.;
- Sullivan, Ryan J.;
- Harding, James J.;
- D'Angelo, Sandra;
- Dickson, Mark;
- Schwartz, Gary K.;
- Chapman, Paul B.;
- Wolchok, Jedd D.;
- Hodi, F. Stephen;
- Carvajal, Richard D.
Publication type:
Article
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival.
Published in:
2010
By:
- Ku GY;
- Yuan J;
- Page DB;
- Schroeder SE;
- Panageas KS;
- Carvajal RD;
- Chapman PB;
- Schwartz GK;
- Allison JP;
- Wolchok JD;
- Ku, Geoffrey Y;
- Yuan, Jianda;
- Page, David B;
- Schroeder, Sebastian E A;
- Panageas, Katherine S;
- Carvajal, Richard D;
- Chapman, Paul B;
- Schwartz, Gary K;
- Allison, James P;
- Wolchok, Jedd D
Publication type:
journal article
Single-Institution Experience With Ipilimumab in Advanced Melanoma Patients in the Compassionate Use Setting.
Published in:
Cancer (0008543X), 2010, v. 116, n. 7, p. 1767, doi. 10.1002/cncr.24951
By:
- Ku, Geoffrey V.;
- Yuan, Jianda;
- Page, David B.;
- Schroeder, Sebastian E. A.;
- Panageas, Katherine S.;
- Carvajal, Richard D.;
- Chapman, Paul B.;
- Schwartz, Gary K.;
- Allison, James P.;
- Wolchok, Jedd D.
Publication type:
Article
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors.
Published in:
Oncologist, 2024, v. 29, n. 1, p. e131, doi. 10.1093/oncolo/oyad215
By:
- Garralda, Elena;
- Schram, Alison M;
- Bedard, Philippe L;
- Schwartz, Gary K;
- Yuen, Eunice;
- McNeely, Samuel C;
- Ribeiro, Silvia;
- Cunningham, Jason;
- Wang, Yi;
- Urunuela, Arantxa;
- Xu, Xiaojian;
- LoRusso, Patricia
Publication type:
Article
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.
Published in:
Oncologist, 2019, v. 24, n. 6, p. 857, doi. 10.1634/theoncologist.2018-0160
By:
- D'Adamo, David R.;
- Dickson, Mark A.;
- Keohan, Mary L.;
- Carvajal, Richard D.;
- Hensley, Martee L.;
- Hirst, Catherine M.;
- Ezeoke, Marietta O.;
- Ahn, Linda;
- Qin, Li‐Xuan;
- Antonescu, Cristina R.;
- Lefkowitz, Robert A.;
- Maki, Robert G.;
- Schwartz, Gary K.;
- Tap, William D.
Publication type:
Article
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.
Published in:
Oncologist, 2015, v. 20, n. 11, p. 1245, doi. 10.1634/theoncologist.2015-0245
By:
- Munhoz, Rodrigo R.;
- D'Angelo, Sandra P.;
- Gounder, Mrinal M.;
- Keohan, Mary L.;
- Chi, Ping;
- Carvajal, Richard D.;
- Singer, Samuel;
- Crago, Aimee M.;
- Landa, Jonathan;
- Healey, John H.;
- Qin, Li‐Xuan;
- Hameed, Meera;
- Ezeoke, Marietta O.;
- Singh, Arun S.;
- Agulnik, Mark;
- Chmielowski, Bartosz;
- Luke, Jason J.;
- Van Tine, Brian A.;
- Schwartz, Gary K.;
- Tap, William D.
Publication type:
Article
Ipilimumab for Patients With Advanced Mucosal Melanoma.
Published in:
Oncologist, 2013, v. 18, n. 6, p. 726, doi. 10.1634/theoncologist.2012-0464
By:
- Postow, Michael A.;
- Luke, Jason J.;
- Bluth, Mark J.;
- Ramaiya, Nikhil;
- Panageas, Katherine S.;
- Lawrence, Donald P.;
- Ibrahim, Nageatte;
- Flaherty, Keith T.;
- Sullivan, Ryan J.;
- Ott, Patrick A.;
- Callahan, Margaret K.;
- Harding, James J.;
- D'Angelo, Sandra P.;
- Dickson, Mark A.;
- Schwartz, Gary K.;
- Chapman, Paul B.;
- Gnjatic, Sacha;
- Wolchok, Jedd D.;
- Hodi, F. Stephen;
- Carvajal, Richard D.
Publication type:
Article
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
Published in:
Quality of Life Research, 2022, v. 31, n. 4, p. 1069, doi. 10.1007/s11136-021-02968-1
By:
- Mazza, Gina L.;
- Petersen, Molly M.;
- Ginos, Brenda;
- Langlais, Blake T.;
- Heon, Narre;
- Gounder, Mrinal M.;
- Mahoney, Michelle R.;
- Zoroufy, Alexander J.;
- Schwartz, Gary K.;
- Rogak, Lauren J.;
- Thanarajasingam, Gita;
- Basch, Ethan;
- Dueck, Amylou C.
Publication type:
Article
Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
Published in:
2022
By:
- Mazza, Gina L.;
- Petersen, Molly M.;
- Ginos, Brenda;
- Langlais, Blake T.;
- Heon, Narre;
- Gounder, Mrinal M.;
- Mahoney, Michelle R.;
- Zoroufy, Alexander J.;
- Schwartz, Gary K.;
- Rogak, Lauren J.;
- Thanarajasingam, Gita;
- Basch, Ethan;
- Dueck, Amylou C.
Publication type:
Correction Notice

Found: 65